Clinical Trials Directory

Trials / Unknown

UnknownNCT03074253

Cardiovascular Imaging and Biomarker Analyses (CIBER)

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Universitätsmedizin Mannheim · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

"Cardiovascular Imaging and Biomarker Analyses (CIBER)" is a single-center, prospective and observational study evaluating the expression of novel biomarkers in patients undergoing cardiacvascular imaging within clinical routine care. It is aimed to evaluate associations with biomarker expressions with ascertained cardiac imaging parameters.

Detailed description

"Cardiovascular Imaging and Biomarker Analyses (CIBER)" is a single-center, prospective and observational study evaluating the expression of novel biomarkers in patients undergoing cardiacvascular imaging within clinical routine care. It is aimed to evaluate associations with biomarker expressions with ascertained cardiac imaging parameters. Furthermore the prognostic value of biomarkers and imaging parameters on mid-term and long-term prognosis will be evaluated. Novel biomarkers will comprise blood derived biomarkers including neurohormones, proteins, cytokines, microRNAs and metabolomics.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiographyPatients are undergoing echocardiography
DIAGNOSTIC_TESTmagnetic resonance imagingPatients are undergoing magnetic resonance imaging
DIAGNOSTIC_TESTcomputed tomographyPatients are undergoing computed tomography
DIAGNOSTIC_TESTblood withdrawlPeripheral blood samples are being collected from all patients

Timeline

Start date
2014-12-01
Primary completion
2020-07-01
Completion
2021-07-01
First posted
2017-03-08
Last updated
2019-10-31

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03074253. Inclusion in this directory is not an endorsement.